Bioactive Oxylipins Profile in Marine Microalgae
Marine Drugs · 2023
DOI: 10.3390/md21030136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Amandyne Linares-Maurizi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut des Biomolécules Max Mousseron, IBMM, Université de Montpellier, CNRS, ENSCM, 34093 Montpellier, France. Hauptthemen laut MEDLINE: Microalgae, Fatty Acids, Omega-3. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association Nationale de la Recherche et de la Technologie, ANRT CIFRE.
Abstract (Originalsprache)
Microalgae are photosynthetic microscopic organisms that serve as the primary food source in aquatic environments. Microalgae can synthesize a wide variety of molecules, such as polyunsaturated fatty acids (PUFAs) of the omega-3 and omega-6 series. Oxidative degradation of PUFA due to radical and/or enzymatic conversion leads to the formation of oxylipins, which are compounds known for their bioactive properties. In the present study, we aim to profile oxylipins from five microalgae species grown in 10-L photo-bioreactors under optimal conditions. During their exponential phase, microalgae were harvested, extracted and analyzed by LC-MS/MS to determine the qualitative and quantitative profile of oxylipins for each species. The five different selected microalgae revealed a high diversity of metabolites, up to 33 non-enzymatic and 24 enzymatic oxylipins present in different concentrations. Taken together, these findings highlight an interesting role of marine microalgae as a source of bioactive lipids mediators, which we hypothesize have an important function in preventive health measures such as amelioration of inflammation. The rich mixture of oxylipins may display advantages to biological organisms, especially by providing for human health benefits including antioxidant, anti-inflammatory, neuroprotective or immunomodulator activities. Some oxylipins are also well known for their cardiovascular properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut des Biomolécules Max Mousseron, IBMM, Université de Montpellier, CNRS, ENSCM, 34093 Montpellier, France.
- Microphyt, 713 Route de Mudaison, 34670 Baillargues, France.
- MetaToul, MetaboHUB, Inserm/UPS UMR 1048, I2MC, Institut des Maladies Métaboliques et Cardiovasculaires, 31077 Toulouse, France.
ORCID-Profile: Camille Oger, Laurence Balas, Justine Bertrand-Michel, Claire Vigor
Förderung
- Association Nationale de la Recherche et de la Technologie
- ANRT CIFRE
Zitieren
APA
Linares-Maurizi, A., Reversat, G., Awad, R., Bultel-Poncé, V., Oger, C., Galano, J. M., Balas, L., Durbec, A., Bertrand-Michel, J., Durand, T., Pradelles, R., & Vigor, C. (2023). Bioactive Oxylipins Profile in Marine Microalgae. Marine Drugs. https://doi.org/10.3390/md21030136
Vancouver
Linares-Maurizi A, Reversat G, Awad R, Bultel-Poncé V, Oger C, Galano JM, et al. Bioactive Oxylipins Profile in Marine Microalgae. Marine Drugs. 2023. doi:10.3390/md21030136
BibTeX
@article{LinaresMaurizi2023,
author = {Linares-Maurizi, Amandyne and Reversat, Guillaume and Awad, Rana and Bultel-Poncé, Valérie and Oger, Camille and Galano, Jean-Marie and Balas, Laurence and Durbec, Anaelle and Bertrand-Michel, Justine and Durand, Thierry and Pradelles, Rémi and Vigor, Claire},
title = {Bioactive Oxylipins Profile in Marine Microalgae},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21030136}
}
EUVIMED